In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Ava J DorazioDepartment of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0009-0007-8148-8835 Ellen G KlineDepartment of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0009-0006-7167-6368 Kevin M SquiresDepartment of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Sunish ShahAntibiotic Management Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Daria Van TyneDepartment of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-7284-0103 Janet Y WuDepartment of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
Ryan K ShieldsDepartment of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-9794-5665 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Twelve pairs of baseline and post-exposure
Indexed as
Anti-Bacterial AgentsAzabicyclo Compoundsbeta-LactamsCeftazidimePseudomonas aeruginosaAmino Acid SubstitutionBacterial Outer Membrane ProteinsBacterial Proteinsbeta-LactamasesCefepimeCefiderocolCephalosporinsCyclooctanesDrug CombinationsDrug Resistance, Multiple, BacterialHumansAmpC beta-lactamasesAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Outer Membrane ProteinsBacterial Proteinsbeta-Lactamasesbeta-LactamsCefepimecefepime-zidebactamCefiderocolCeftazidimeceftolozane, tazobactam drug combinationCephalosporinsCyclooctanesDrug CombinationsImipenemMembrane Transport ProteinsMexA protein, Pseudomonas aeruginosaMexB protein, Pseudomonas aeruginosaOprM protein, Pseudomonas aeruginosaPenicillanic AcidPiperidinesrelebactamTazobactamAmpCcefepime-zidebactamceftazidime-avibactamceftolozane-tazobactamMexAB-OprM efflux systemβ-lactam cross-resistance
Identifiers
PMID41940815
PMCPMC13148059
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390